Repro Med Systems Stock Today
| KRMD Stock | USD 2.20 0.06 2.80% |
Performance1 of 100
| Odds Of DistressLess than 9
|
Repro Med is trading at 2.20 as of the 24th of April 2024, a 2.80 percent up since the beginning of the trading day. The stock's lowest day price was 2.13. Repro Med has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat weak performance during the last 90 days. Equity ratings for Repro Med Systems are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of March 2024 and ending today, the 24th of April 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | IPO Date 20th of March 1996 | Category Healthcare | Classification Health Care |
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York. The company has 46.57 M outstanding shares of which 1.05 M shares are now shorted by private and institutional investors with about 8.83 trading days to cover. More on Repro Med Systems
Moving together with Repro Stock
| 0.61 | NXL | Nexalin Technology | PairCorr |
Moving against Repro Stock
| 0.45 | UNH | UnitedHealth Group Financial Report 12th of July 2024 | PairCorr |
| 0.45 | SINT | SINTX Technologies | PairCorr |
Repro Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Repro Med's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Repro Med or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Linda Tharby | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) | ||||
| Average Analyst Recommendation Analysts covering Repro Med report their recommendations after researching Repro Med's financial statements, talking to executives and customers, or listening in on Repro Med's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Repro Med Systems. The Repro consensus assessment is calculated by taking the average forecast from all of the analysts covering Repro Med. | |||||
Repro Med's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Repro Med's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Repro Med's financial leverage. It provides some insight into what part of Repro Med's total assets is financed by creditors.
| |||||
Repro Med Systems (KRMD) is traded on NASDAQ Exchange in USA. It is located in 100 Corporate Drive, Mahwah, NJ, United States, 07430 and employs 82 people. Repro Med is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 99.67 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Repro Med's market, we take the total number of its shares issued and multiply it by Repro Med's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Repro Med Systems conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 46.57 M outstanding shares of which 1.05 M shares are now shorted by private and institutional investors with about 8.83 trading days to cover.
Repro Med Systems currently holds about 18.27 M in cash with (4.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41.
Check Repro Med Probability Of Bankruptcy
Ownership AllocationRepro Med Systems has a total of 46.57 Million outstanding shares. Over half of Repro Med's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in Repro Med. Please watch out for any change in the institutional holdings of Repro Med Systems as this could mean something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Repro Ownership Details
Repro Stock Price Odds Analysis
What are Repro Med's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Repro Med jumping above the current price in 90 days from now is about 35.81%. The Repro Med Systems probability density function shows the probability of Repro Med stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.6753. This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Repro Med will likely underperform. Additionally, repro Med Systems has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Repro Med to move above the current price in 90 days from now is about 35.81 (This Repro Med Systems probability density function shows the probability of Repro Stock to fall within a particular range of prices over 90 days) .
Repro Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Repro Med that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Repro Med's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Repro Med's value.| Instituion | Recorded On | Shares | |
| Keybank National Association | 2023-12-31 | 216.2 K | |
| Empire Financial Management Company, Llc | 2023-12-31 | 107 K | |
| Washington Trust Co | 2023-12-31 | 100 K | |
| Bank Of New York Mellon Corp | 2023-12-31 | 97.7 K | |
| Pnc Financial Services Group Inc | 2023-12-31 | 97 K | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 92.7 K | |
| Morgan Stanley - Brokerage Accounts | 2023-12-31 | 75.6 K | |
| Lakewood Asset Management Llc | 2023-12-31 | 59.9 K | |
| White Pine Capital Llc | 2023-12-31 | 56.1 K | |
| First Light Asset Management, Llc | 2023-12-31 | 5.2 M | |
| Archon Capital Management Llc | 2023-12-31 | 3.7 M |
Repro Med Historical Income Statement
Repro Med Systems Income Statement is one of the three primary financial statements used for reporting Repro's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Repro Med Systems revenue and expense. Repro Med Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Repro Med's Total Revenue is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 16.6 M, whereas Operating Income is projected to grow to (9.8 M). View More FundamentalsRepro Stock Against Markets
Picking the right benchmark for Repro Med stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Repro Med stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Repro Med is critical whether you are bullish or bearish towards Repro Med Systems at a given time. Please also check how Repro Med's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Repro Med without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Repro Med Corporate Management
Elected by the shareholders, the Repro Med's board of directors comprises two types of representatives: Repro Med inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Repro. The board's role is to monitor Repro Med's management team and ensure that shareholders' interests are well served. Repro Med's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Repro Med's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Brian Case | Chief Officer | Profile | |
| Thomas Adams | Chief Officer | Profile | |
| Rob Cannon | Vice Sales | Profile | |
| Josh Bennett | VP Devel | Profile | |
| Kenneth Miller | Chief Officer | Profile | |
| Tom Adams | Interim Officer | Profile |
How to buy Repro Stock?
Before investing in Repro Med, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Repro Med. To buy Repro Med stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Repro Med. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Repro Med stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Repro Med Systems stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Repro Med Systems stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Repro Med Systems, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Repro Stock please use our How to Invest in Repro Med guide.
Already Invested in Repro Med Systems?
The danger of trading Repro Med Systems is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Repro Med is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Repro Med. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Repro Med Systems is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Repro Med Systems. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Complementary Tools for Repro Stock analysis
When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Repro Med's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.66) | Earnings Share (0.30) | Revenue Per Share 0.625 | Quarterly Revenue Growth (0.02) | Return On Assets (0.18) |
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.